Email this article Combined operations in conjunction with intracavitary chemotherapy for treatment of patients with peritoneal mesothelioma. Immediate results. Experience of the Thoracic Department of the N.N. Blokhin Russian Cancer Research Center of RAMS
- Authors: Abdullaev A.G1, Polotskiy B.E1, Davydov M.I1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences
- Issue: Vol 19, No 2 (2014)
- Pages: 12-15
- Section: Articles
- URL: https://journal-vniispk.ru/1028-9984/article/view/40028
- DOI: https://doi.org/10.17816/onco40028
- ID: 40028
Cite item
Full Text
Abstract
The paper presents a detailed analysis of the immediate results of the treatment of patients with peritoneal mesothelioma who underwent cytoreductive surgery combined with intracavitary hyperthermia chemoperfusion in the thoracic department of the N.N. Blokhin Russian Cancer Research Center in the period from 2008 to 2013.
Full Text
##article.viewOnOriginalSite##About the authors
A. G Abdullaev
N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences
Email: agulsky@rambler.ru
научн. сотр. отд-ния хирургического торакального НИИ клинической онкологии 115478, Moscow, Russian Federation
B. E Polotskiy
N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences115478, Moscow, Russian Federation
M. I Davydov
N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences115478, Moscow, Russian Federation
References
- Tan G.H., Cheung M., Chanyaputhipong J., Soo K.C., Teo M.C. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritonealmesothelioma. Ann. Acad. Med. Singapore. 2013; 42 (6): 291-6.
- Turner K., Varghese S., Alexander H.R. Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma. J. Natl. Compr. Cancer Netw. 2012; 10 (1): 49-57.
- Deraco M., Nonaka D., Baratti D. et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann. Surg. Oncol. 2006; 13 (2): 229-37.
- Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann. Surg. 2004; 240 (2): 278-85.
- Canda A.E., Sokmen S., Terzi C. et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann. Surg. Oncol. 2013; 20 (4):1082-7. doi: 10.1245/s10434-012-2853-x. Epub 2013 Mar 2.
- Robella M., Vaira M., Marsanic P. et al. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience. Minerva Chir. 2013; 68 (6): 569-77.
- Беляев А.М., Багненко С.Ф., Рухляда Н.В. Внутрибрюшинная химиотерапия злокачественных опухолей брюшной полости. Монография. СПб.: ЭЛБИ-СПб; 2007.
Supplementary files
